HomeComparePRAC vs MRK

PRAC vs MRK: Dividend Comparison 2026

PRAC yields 644.44% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRAC wins by $460997.76M in total portfolio value
10 years
PRAC
PRAC
● Live price
644.44%
Share price
$0.05
Annual div
$0.29
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$460997.82M
Annual income
$353,188,015,555.96
Full PRAC calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PRAC vs MRK

📍 PRAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRACMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRAC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRAC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRAC
Annual income on $10K today (after 15% tax)
$54,777.78/yr
After 10yr DRIP, annual income (after tax)
$300,209,813,222.57/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, PRAC beats the other by $300,209,804,625.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRAC + MRK for your $10,000?

PRAC: 50%MRK: 50%
100% MRK50/50100% PRAC
Portfolio after 10yr
$230498.94M
Annual income
$176,594,012,834.87/yr
Blended yield
76.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PRAC
No analyst data
Altman Z
0.6
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRAC buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRACMRK
Forward yield644.44%2.81%
Annual dividend / share$0.29$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$460997.82M$57.7K
Annual income after 10y$353,188,015,555.96$10,113.78
Total dividends collected$452128.96M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRAC vs MRK ($10,000, DRIP)

YearPRAC PortfolioPRAC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$75,144$64,444.44$11,213$373.04+$63.9KPRAC
2$532,988$452,583.36$12,667$512.06+$520.3KPRAC
3$3,570,394$3,000,096.97$14,439$708.14+$3.56MPRAC
4$22,602,688$18,782,366.07$16,640$988.16+$22.59MPRAC
5$135,309,539$111,124,663.21$19,432$1,394.07+$135.29MPRAC
6$766,501,453$621,720,246.10$23,057$1,992.90+$766.48MPRAC
7$4,111,671,265$3,291,514,710.55$27,889$2,894.79+$4111.64MPRAC
8$20,900,760,332$16,501,272,078.47$34,518$4,286.29+$20900.73MPRAC
9$100,756,824,970$78,393,011,414.19$43,912$6,494.35+$100756.78MPRAC
10$460,997,818,273$353,188,015,555.96$57,714$10,113.78+$460997.76MPRAC

PRAC vs MRK: Complete Analysis 2026

PRACStock

Productivity Technologies Corp., through its subsidiaries, manufactures and sells automated industrial systems, industrial machinery and equipment, and custom electrical control panels. The company offers quick die change, press automation, flexible transfer, and stacking/destacking equipment used to automate automotive and other metal stamping operations. In addition, the company engages in the design, manufacture, and installation of custom electrical control panels primarily for use in production machinery and machine tools utilized in automotive, adhesive and sealant, food processing, and other industrial applications. It sells its products to automobile and automotive parts manufacturers, appliance manufacturers, and steel service centers, as well as manufacturers of lawn and garden equipment, office furniture, heating, ventilation and air conditioning equipment, and large construction equipment in the United States and internationally. Productivity Technologies Corp. was formerly known as Production Systems Acquisition Corporation and changed its name to Productivity Technologies Corp. in May 1996. The company was incorporated in 1993 and is based in Fenton, Michigan. It has sales and engineering offices in Michigan, Germany, and China.

Full PRAC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PRAC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRAC vs SCHDPRAC vs JEPIPRAC vs OPRAC vs KOPRAC vs MAINPRAC vs JNJPRAC vs ABBVPRAC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.